Timetable
Subject to change
Thursday, September 7, 2023
|
||
| Hall A |
Hall B | |
| 16:00 – 17:45 | Pre-Congress Industry Symposium | |
| 18:30 – 21:00 | Dinner Symposium | |
Friday, September 8, 2023
|
||
| Hall A |
Hall B |
|
| 08:45 – 09:00 | Congress opening |
|
| 09:00 – 10:00 | Plenary Session 1: Neoadjuvant therapy: HER2 negative/positive What to do after neoadjuvant |
|
| 10:00 – 11:00 | Plenary Session 2: Adjuvant endocrine therapy |
|
| 11:00 – 11:30 | Coffee break, poster viewing and exhibition visit | |
| 11:30 – 12:30 | Session 3: Tumour Board: Early disease |
Session 4: Surgical |
| 12:30 – 13:30 | Lunch break, poster viewing and exhibition visit | |
| 13:30 – 14:30 | Session 5: Satellite symposium |
|
| 14:30 – 15:30 | Session 6: Advanced triple negative disease |
Session 7: Imaging |
| 15:30 – 16:00 | Coffee break, poster viewing and exhibition visit | |
| 16:00 – 17:00 | Session 8: Tumour Board: Advanced disease |
|
Saturday, September 9, 2023
|
||
| Hall A |
Hall B |
|
| 09:00 – 10:00 | Session 9: HER2 low breast cancer |
Session 10: Free papers |
| 10:00 – 11:00 | Plenary Session 11: Oligometastatic disease |
|
| 11:00 – 11:30 | Coffee break, poster viewing and exhibition visit | |
| 11:30 – 12:30 | Session 12: Satellite Symposium: Localisation Supported by Merit |
|
| 12:30 – 13:30 | Lunch break, poster viewing and exhibition visit | |
| 13:30 – 14:30 | Session 13: Who gets chosen for molecular testing |
Session 14: Free papers |
| 14:30 – 15:30 | Session 15: Breast cancer 2030 |
|
| 15:30 – 15:45 | Congress closing and award presentation | |